<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) is defined as the presence of repeated episodes of arterial or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, recurrent <z:hpo ids='HP_0005268'>spontaneous abortions</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> in patients with elevated <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>An important feature of APS are cerebrovascular disorders of thrombotic origin </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of the study was to assess cerebral blood flow changes utilising brain SPECT HMPAO scanning </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Brain SPECT (99m)Tc-HMPAO scanning was performed in 20 patients with APS: 12 with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, 4 with <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e>, 2 with <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sj√∂gren's syndrome</z:e>, 2 with primary APS </plain></SENT>
<SENT sid="4" pm="."><plain>30 healthy volunteers served as a control group </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: 19 studies were abnormal, 1 <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Abnormalities consisted of multifocal perfusion deficits and diffuse decrease of regional blood flow </plain></SENT>
<SENT sid="7" pm="."><plain>The average number of focal perfusion deficits was 4.8 +/- 1.7 </plain></SENT>
<SENT sid="8" pm="."><plain>In 7 patients diffuse hypoperfusion of frontal lobes was seen, in 1 patient additionally hypoperfusion of temporal and occipital lobes </plain></SENT>
<SENT sid="9" pm="."><plain>There was a correlation between the number of focal perfusion deficits and <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> in this group of patients </plain></SENT>
<SENT sid="10" pm="."><plain>Correlation between SPECT images and clinical data was moderate in <z:e sem="disease" ids="C0007760" disease_type="Disease or Syndrome" abbrv="">cerebellar syndrome</z:e> and <z:mp ids='MP_0000754'>paresis</z:mp>, weak in persistent <z:hpo ids='HP_0002315'>headache</z:hpo> and <z:hpo ids='HP_0002321'>vertigo</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Those results indicate the high utility of CBF brain SPECT scanning in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>